Imunoglukan Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
50
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Imunoglukan General Information
Description
Manufacturer of immunity-focused dietary supplements intended to boost the immunity of consumers. The company engages in research, development and sale of immunity medicines and dietary supplements, it manufactures imunoglukan which is a highly purified natural substance, the complex of biologically active polysaccharides obtained through the isolation from Pleurotus ostreatus.
Contact Information
Website
www.imunoglukan.comCorporate Office
- Nove Zahrady I c. 13/A
- Bratislava, 821 05
- Slovakia
Corporate Office
- Nove Zahrady I c. 13/A
- Bratislava, 821 05
- Slovakia
Imunoglukan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Imunoglukan Patents
Imunoglukan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3858362-A1 | Beta-glucan for use in enhancement of anti-tumor immunity in remission | Active | 29-Jan-2020 | ||
| EP-4096685-A1 | Beta-glucan for use in modulation of an immune response in a remission | Pending | 29-Jan-2020 | ||
| US-20230045997-A1 | Beta-glucan for use in modulation of an immune response in a remission | Pending | 29-Jan-2020 | ||
| WO-2021152497-A1 | Beta-glucan for use in modulation of an immune response in a remission | Inactive | 29-Jan-2020 | ||
| EP-3858362-B1 | Beta-glucan for use in the treatmane of a remission | Active | 29-Jan-2020 | A61K31/716 |
Imunoglukan Signals
Imunoglukan Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Imunoglukan FAQs
-
When was Imunoglukan founded?
Imunoglukan was founded in 2000.
-
Where is Imunoglukan headquartered?
Imunoglukan is headquartered in Bratislava, Slovakia.
-
What is the size of Imunoglukan?
Imunoglukan has 50 total employees.
-
What industry is Imunoglukan in?
Imunoglukan’s primary industry is Other Consumer Non-Durables.
-
Is Imunoglukan a private or public company?
Imunoglukan is a Private company.
-
What is Imunoglukan’s current revenue?
The current revenue for Imunoglukan is .
-
Who are Imunoglukan’s investors?
Hartenberg Holding has invested in Imunoglukan.
-
When was Imunoglukan acquired?
Imunoglukan was acquired on 01-Aug-2024.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process